Dabrafenib Mesylate and Nexium (Esomeprazole Delayed-Release Capsules)
Determining the interaction of Dabrafenib Mesylate and Nexium (Esomeprazole Delayed-Release Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: esomeprazole
Brand name: Nexium, Esomeprazole Strontium, Nexium, NexIUM 24HR, Nexium IV
Synonyms: Nexium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Nexium (Esomeprazole Powder for Suspension)
- Dabrafenib Mesylate-Nexium 24HR (Esomeprazole Delayed-Release Capsules)
- Dabrafenib Mesylate-NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
- Dabrafenib Mesylate-Nexium Capsules
- Dabrafenib Mesylate-Nexium I.V.
- Dabrafenib Mesylate-Nexium I.V. Injection
- Nexium (Esomeprazole Delayed-Release Capsules)-Dacarbazine
- Nexium (Esomeprazole Delayed-Release Capsules)-Dacarbazine Intravenous, Injection
- Nexium (Esomeprazole Delayed-Release Capsules)-Daclatasvir
- Nexium (Esomeprazole Delayed-Release Capsules)-Daclatasvir Dihydrochloride
- Nexium (Esomeprazole Delayed-Release Capsules)-Daclizumab
- Nexium (Esomeprazole Delayed-Release Capsules)-Daclizumab Subcutaneous